Deloitte May 10, 2019

A new report in ‘Harvard Business Review’ by Thomas H. Davenport, James Guszcza, and Greg Szwartz

Thomas H. Davenport is a professor at Babson College, a research fellow at the MIT Initiative on the digital economy, and a senior adviser at Deloitte Analytics. James Guszcza is the US chief data scientist for Deloitte Consulting LLP. Greg Szwartz is a managing director of advanced analytics for Deloitte Consulting LLP.

Health care practitioners and payer organizations increasingly use big data to overcome what might be called a “flaw of averages” in traditional medicine: a treatment that has been tested at a population level might, in fact, work better for some individuals than others. The goal...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Biotechnology, Health System / Hospital, Patient / Consumer, Physician, Precision Medicine, Provider, Technology
FDA launches initiative to advance home healthcare models, devices
HHS releases national suicide prevention strategy, plan
Opinion: Balancing hope and reality: The promise and peril of blood-based colorectal cancer screening
A new kind of gene-edited pig kidney was just transplanted into a person
Patient Engagement Is Essential for Achieving the Goals of Value-Based Care

Share This Article